Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries.
about
Chemical and biological work-related risks across occupations in Europe: a reviewCurrent strategies for managing providers infected with bloodborne pathogensIncidence rate of needlestick and sharps injuries in 67 Japanese hospitals: a national surveillance studySerosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.The prevention of infection-associated cancersSeroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, IranHepatitis B infection in microbiology laboratory workers: prevalence, vaccination, and immunity status.Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitisKnowledge and Practice on Injection Safety among Primary Health Care Workers in Kaski District, Western Nepal.Hepatitis B in health care workers: Indian scenario.Seroprevalence of hepatitis B virus infection and hepatitis B surface antibody status among laboratory health care workers in Isfahan, Iran.Fluctuation of Viremia in Hepatitis B Virus-Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands.Changing times, changing landscapes: comparing the Society for Healthcare Epidemiology of America's infected provider guidelines with the Centers for Disease Control and Prevention's Guidelines for managing providers INFECTED with hepatitis B virus.The comparison of sharps injuries reported by doctors versus nurses from surgical wards in the context of the prevalence of HBV, HCV and HIV infections.
P2860
Q26826869-42A6CF0D-940E-4E37-8C21-7B8CE45BC461Q30360452-23D60315-462B-4F3A-80BD-1808721574E8Q30416403-3474D42D-A92C-4AE8-B6B5-28BEFE193FC0Q35416927-AD46C7AB-4AFE-47D8-96A1-A62DAB2B4380Q35857515-DA61F070-2E76-47A8-A4FB-DC09ED69D1C8Q36101928-13564C00-8E69-4074-8D1B-4CF433D13613Q36486399-4ED9949F-E56D-4390-B115-F3CE33D2FC3CQ36559497-40DF3934-3228-4CBA-93F6-3B3695C53E55Q37155870-B9AA18EC-8D8C-40B1-8C7B-5A3587E18F0BQ37936831-BBD84C1D-F4D3-41CA-AFAB-95BEC22F4871Q40484337-CA779303-6BEC-4D37-AB9A-5AC4B101E3FCQ40667034-52D5BA67-6995-4F3B-8DEC-59C5F20661A5Q45354459-77662BFD-C975-4923-BD02-4447114FA802Q46896485-0ADDDA50-9048-46E7-81F2-32928DFCEE97
P2860
Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@en
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@nl
type
label
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@en
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@nl
prefLabel
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@en
Hepatitis B virus, hepatitis C ...... t in industrialised countries.
@nl
P2093
P50
P356
P1476
Hepatitis B virus, hepatitis C ...... nt in industrialised countries
@en
P2093
A Prüss-Ustün
D FitzSimons
D Lavanchy
G François
I Williams
P Van Damme
P304
P356
10.1136/OEM.2006.032334
P577
2008-07-01T00:00:00Z